Benvenue Medical to attend 33rd Annual J.P. Morgan Healthcare Conference

Benvenue Medical CEO Robert Weigle will present at the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco, Jan. 12 to 15.

Advertisement

Benvenue Medical focuses on providing next generation minimally invasive systems for spine repair. Recently, its Luna 360 Interbody Fusion System received 510(k) clearance from the U.S. Food and Drug Administration for spinal fusion treatment of symptomatic degenerative disc disease.

More articles on devices:

8 key medtech industry trends in 2015
Mazor Robotics sells 6 systems, projects 4Q revenue at $5.7M — 5 things to know
Noridian now covers MIS SI joint fusion — 3 quick facts

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.